current
diagnost
method
detect
streptococcu
pneumonia
children
suspect
invas
pneumococc
diseas
limit
accuraci
timeli
patient
conveni
studi
aim
determin
perform
pneumococc
load
quantifi
realtim
polymerasechain
reaction
nasopharyng
sampl
diagnos
invas
pneumococc
diseas
children
match
casecontrol
studi
patient
year
age
invas
pneumococc
diseas
admit
district
hospit
mozambiqu
asymptomat
control
recruit
differ
period
case
confirm
posit
bacteri
cultur
pneumonia
blood
cerebrospin
fluid
nasopharyng
aspir
collect
case
control
pneumococc
densiti
quantifi
lyta
realtim
polymerasechain
reaction
thirti
case
median
age
month
sixti
control
median
age
month
enrol
male
nasopharyng
pneumococc
carriag
high
group
case
vs
control
p
mean
gramposit
bacterium
streptococcu
pneumonia
pneumonia
frequent
colon
child
nasopharynx
remain
one
major
killer
children
global
despit
extens
pneumococc
vaccin
program
occasion
colon
pneumococci
spread
nasopharyng
np
nich
normal
steril
bodi
site
caus
potenti
lifethreaten
invas
pneumococc
diseas
ipd
complex
mechan
underli
transit
np
colon
ipd
far
fulli
understood
although
number
environment
host
pathogenrel
risk
factor
identifi
diagnosi
ipd
remain
challeng
children
requir
collect
invas
sampl
use
sensit
method
detect
pneumonia
small
sampl
volum
culturebas
method
steril
fluid
insensit
timeconsum
rapid
simpl
noninvas
pneumococc
antigen
detect
test
urin
becom
mainstay
screen
pneumococc
infect
adult
show
poor
specif
children
rel
quick
realtim
polymerasechain
reaction
pcr
assay
target
lyta
gene
accur
detect
pneumonia
small
volum
invas
noninvas
pediatr
sampl
easili
access
feasibl
addit
sinc
ipd
mani
common
pediatr
condit
share
overlap
clinic
present
empir
diagnosi
without
microbiolog
confirm
result
antibiot
misus
increas
antimicrobi
resist
commun
np
pneumococc
load
measur
realtim
pcr
cultur
noninvas
sampl
collect
upper
respiratori
tract
propos
candid
surrog
marker
discrimin
ipd
asymptomat
carriag
albeit
conflict
evid
studi
aim
determin
whether
pneumococc
load
quantifi
lyta
realtim
pcr
np
aspir
taken
rural
mozambican
pediatr
popul
could
marker
ipd
also
take
account
divers
pathogenand
hostrel
potenti
risk
factor
surveil
system
district
hospit
mdh
cover
area
time
studi
around
km
peopl
perman
surveil
less
year
age
rural
area
coendem
malaria
sever
affect
human
immunodefici
viru
hiv
pandem
tenval
pneumococc
conjug
vaccin
introduc
mozambiqu
march
case
ipd
prospect
select
among
inpati
year
age
recruit
part
invas
bacteri
diseas
pneumonia
clinic
studi
mdh
period
septemb
sign
inform
consent
mother
legal
guardian
initi
treatment
np
aspir
collect
case
control
determin
pneumococc
load
respiratori
viral
infect
venou
blood
collect
blood
cultur
full
blood
cell
count
hiv
malaria
test
two
asymptomat
control
ipd
age
month
sex
randomli
select
commun
case
dss
databas
recruit
period
septembernovemb
span
hot
raini
season
dri
cooler
season
studi
clinician
confirm
healthi
prior
recruit
variabl
record
case
control
includ
patient
age
sex
height
weight
weightforag
z
waz
score
nutrit
statu
recruit
season
coinfect
hiv
malaria
np
carriag
lyta
posit
np
pneumococc
load
among
lyta
posit
sampl
pneumococc
serotyp
identif
serotyp
invas
potenti
presenc
cocolon
pneumococci
respiratori
virus
nasopharynx
blood
marker
measur
upon
recruit
studi
children
receiv
antibiot
previou
month
exclud
studi
ipd
defin
isol
pneumonia
blood
cerebrospin
fluid
cultur
nutrit
statu
establish
accord
weightforag
zscore
children
weightforag
zscore
dispers
consid
undernourish
hot
raini
season
defin
novemb
april
dri
cooler
season
may
octob
serogroup
serotyp
consid
high
invas
diseas
potenti
previous
describ
np
aspir
method
select
best
procedur
reduc
discomfort
infant
young
children
sampl
np
specimen
collect
use
npak
kit
mpro
michigan
us
process
aliquot
obtain
inject
small
ml
amount
physiolog
salin
aspir
immedi
frozen
frozen
sampl
ship
hospit
sant
joan
de
hospit
clinic
barcelona
spain
pneumococc
respiratori
viru
studi
conduct
respect
detect
quantif
pneumonia
sampl
standard
refer
control
strain
extract
concentr
nuclisen
easymag
marci
letoil
franc
initi
sampl
volum
elut
volum
five
micro
liter
dna
extract
ad
pcr
reaction
mix
duplex
realtim
pcr
target
lyta
gene
pneumonia
intern
control
target
rnasep
human
cell
perform
sequenc
primer
probe
recommend
cdc
pathogen
intern
control
use
http
wwwcdcgovmeningitislabmanu
dna
amplifi
appli
biosystem
realtim
pcr
system
appli
biosystem
ca
us
determin
pcr
effici
calibr
curv
dna
quantif
calibr
curv
correl
dna
pneumococc
load
cycl
threshold
valu
perform
use
refer
strain
pneumonia
given
genomecopi
number
less
variabl
coloni
form
unit
cfu
establish
standard
load
quantifi
genomecopi
number
higher
cfu
calibr
curv
gener
extract
genom
dna
origin
suspens
pneumonia
strain
od
perform
serial
dilut
rang
copi
per
ml
cpml
pneumococc
serotyp
capsular
type
pneumococci
directli
perform
lyta
posit
sampl
without
cultur
multiplex
pcr
combin
autom
fluoresc
capillari
electrophoresi
accord
previou
method
publish
group
nondetect
serotyp
techniqu
classifi
indistinguish
serotyp
consid
noninvas
studi
invas
potenti
patient
indistinguish
serotyp
exclud
analysi
pneumococc
cocolon
possibl
assess
number
nonidentifi
colon
serotyp
subject
detect
respiratori
virus
detect
influenza
b
c
respiratori
syncyti
viru
adenoviru
coronaviru
enteroviru
human
parainfluenza
virus
human
rhinoviru
human
metapneumoviru
perform
accord
previous
publish
studi
determin
hiv
malaria
statu
serodiagnosi
perform
use
sequenti
test
algorithm
two
rapid
antibodi
test
determin
unigold
hivinfect
confirm
necessari
dna
amplicor
test
version
roch
molecular
system
inc
branchburg
nj
us
thick
thin
blood
film
process
examin
accord
standard
method
malaria
diagnosi
dichotom
variabl
examin
chisquar
test
fisher
exact
test
continu
variabl
describ
mean
standard
deviat
sd
median
valu
interquartil
rang
iqr
compar
use
test
normal
distribut
mann
whitney
test
skew
data
variabl
np
pneumococc
load
copiesml
log
transform
inclus
analysi
assum
normal
distribut
preliminari
comparison
case
control
conduct
ensur
number
factor
interest
differ
distribut
across
group
logist
regress
univari
multivari
analys
perform
identifi
risk
factor
ipd
variabl
found
significantli
associ
ipd
univari
analysi
enter
multivari
model
area
receiv
oper
characterist
curv
aucroc
paramet
use
select
accur
predict
model
determin
optim
cutoff
valu
np
pneumococc
load
maxim
sensit
specif
statist
signific
set
pvalu
confid
interv
ci
level
analys
perform
use
stata
softwar
stata
corp
colleg
station
tx
us
differ
surveil
biomark
studi
case
healthi
control
drawn
approv
mozambiqu
mozambican
nation
bioethic
committe
total
ipd
patient
healthi
control
includ
studi
male
predomin
group
differ
median
age
case
month
control
month
minor
p
twentyf
case
control
recruit
introduct
pneumococc
conjug
vaccin
countri
recruit
influenc
season
case
select
dri
cooler
season
vs
control
p
case
slightli
lower
bodi
weight
control
kg
vs
kg
p
malnutrit
measur
waz
score
significantli
preval
case
vs
p
overal
two
group
show
compar
distribut
valu
potenti
confound
factor
age
sex
recruit
season
among
case
present
bacterem
pneumococc
pneumonia
pneumococc
mening
bacteremia
without
clear
focu
demograph
epidemiolog
characterist
studi
particip
shown
tabl
np
pneumococc
carriag
highli
preval
group
case
vs
control
p
calibr
curv
np
pneumococc
dna
quantif
show
linear
behavior
six
order
magnitud
defin
linear
rang
copiesml
correl
coeffici
r
slope
standard
curv
result
effici
realtim
pcr
paramet
fell
within
accept
limit
previous
establish
among
studi
sampl
quantif
np
pneumococc
load
lyta
realtim
pcr
show
signific
differ
mean
load
case
control
log
copiesml
vs
log
copiesml
p
capsular
type
reveal
case
extens
colon
invas
serotyp
vs
p
frequent
cocolon
differ
serotyp
vs
p
consid
serotyp
carriag
event
separ
group
frequent
serotyp
identifi
case
wherea
control
serotyp
predomin
follow
compar
mean
np
pneumococc
load
case
recruit
introduct
pneumococc
conjug
vaccin
substanti
differ
case
recruit
prevaccin
period
log
copiesml
vs
log
copiesml
p
half
case
test
posit
hiv
hivposit
case
present
significantli
higher
mean
pneumococc
load
hivneg
log
copiesml
vs
log
copiesml
p
note
data
coinfect
hiv
avail
control
sampl
malaria
coinfect
detect
case
respiratori
viral
infect
monoor
multipl
highli
preval
case
control
differ
statist
signific
p
total
virus
detect
case
control
rhinoviru
predomin
find
group
n
case
control
follow
adenoviru
n
four
case
one
control
parainfluenza
viru
n
one
case
one
control
influenza
n
one
case
median
hemoglobin
hb
level
significantli
lower
case
control
gl
vs
gl
p
similarli
median
hematocrit
hct
valu
vs
p
contrast
signific
differ
found
median
platelet
plt
white
blood
cell
wbc
count
tabl
describ
result
laboratori
microbiolog
hematolog
test
two
group
np
pneumococc
load
quantifi
lyta
realtim
pcr
np
pneumococci
cocolon
invas
serotyp
underweight
hb
hct
marker
significantli
associ
ipd
univari
analysi
particularli
np
pneumococc
load
show
good
discriminatori
power
case
control
aucroc
ci
colon
densiti
log
copiesml
determin
optim
cutoff
valu
distinguish
case
control
yield
sensit
specif
valu
respect
fair
diagnost
accuraci
observ
serotyp
invas
aucroc
ci
pneumococc
cocolon
aucroc
ci
underweight
aucroc
ci
hb
hct
poor
predictor
fig
depict
roc
curv
relat
risk
factor
compar
variabl
significantli
associ
ipd
identifi
univari
analysi
consid
multivari
analysi
howev
given
high
colinear
found
hb
hct
correl
coeffici
r
p
decid
includ
hb
model
process
meaning
potenti
marker
ipd
hct
model
includ
np
pneumococc
load
serotyp
invas
hb
prove
highest
predict
power
aucroc
ci
high
level
sensit
specif
adjust
odd
ratio
ipd
per
log
unit
increas
np
pneumococc
load
ci
p
model
result
univari
multivari
analysi
present
tabl
studi
provid
robust
evid
suitabl
pneumococc
bacteri
load
measur
lyta
realtim
pcr
np
aspir
proxi
ipd
diagnosi
children
np
pneumococc
load
adjust
varieti
potenti
host
pathogen
risk
factor
significantli
higher
among
case
healthi
control
abl
identifi
threshold
valu
log
copiesml
discrimin
moder
high
sensit
specif
case
control
idea
discrimin
threshold
new
previous
explor
divers
pneumococc
condit
popul
sampl
type
unequ
conflict
result
studi
anh
et
al
document
high
rate
colon
densiti
log
cfuml
measur
cultur
among
np
swab
sampl
vietnames
children
pneumonia
similarli
high
valu
pneumococc
load
log
copiesml
quantifi
pcr
np
sampl
report
vu
et
al
children
communityacquir
pneumonia
radiolog
confirm
countri
fan
et
al
observ
slightli
lower
densiti
log
copiesml
young
peruvian
children
acut
respiratori
infect
interestingli
threshold
valu
colon
densiti
establish
pediatr
studi
probabl
difficulti
establish
valu
among
children
diseas
carrier
high
np
pneumococc
load
similar
line
albrich
et
al
assess
potenti
quantit
lyta
realtim
pcr
diagnosi
pneumococc
pneumonia
np
swab
south
african
adult
determin
threshold
valu
copiesml
sensit
specif
subsequ
studi
popul
propos
similar
cutoff
valu
copiesml
goodqual
sputum
lyta
realtim
pcr
albeit
slightli
lower
sensit
specif
valu
respect
discrimin
hivinfect
adult
pneumococc
pneumonia
control
stralin
et
al
document
cutoff
valu
copiesml
np
aspir
log
copiesml
sputum
measur
quantit
lyta
realtim
pcr
elder
swedish
pneumonia
cohort
use
realtim
pcr
detect
sputum
sampl
also
postul
yang
et
al
rapid
diagnosi
adult
cap
pneumonia
emerg
depart
group
determin
auc
roc
curv
report
sensit
specif
valu
respect
cutoff
copiesml
specul
differ
cutoff
valu
studi
adult
popul
could
primarili
due
impair
immun
respons
first
year
life
relat
high
rate
carriag
children
addit
differ
sampl
quantif
method
epidemiolog
characterist
given
high
densiti
pneumococc
carriag
log
copiesml
found
case
estim
rel
high
threshold
valu
calcul
studi
log
copiesml
may
diagnost
util
diagnos
pediatr
ipd
trend
synergist
relationship
univari
analysi
respiratori
viru
coinfect
ipd
also
identifi
reach
statist
signific
outcom
disagr
strong
synergist
associ
previous
describ
pediatr
pneumococc
pneumonia
viral
coinfect
pediatr
invas
pneumococc
pneumonia
rhinoviru
coinfect
hypothes
low
preval
influenza
studi
popul
rel
stabl
incid
rhinoviru
infect
throughout
entir
studi
period
could
explain
respiratori
viral
coinfect
found
risk
factor
recent
year
technolog
advanc
allow
integr
molecular
diagnost
small
footprint
devic
perform
fast
simpl
highli
sensit
molecular
assay
point
need
light
diagnost
innov
potenti
implic
applic
find
promis
particularli
pediatr
popul
would
also
benefit
high
diagnost
yield
np
wash
addit
conveni
sampl
method
novel
biomark
np
pneumococc
dna
load
may
allow
design
pointofcar
test
capabl
quantifi
bacteri
load
simpl
manner
addit
result
multivari
analysi
assess
independ
risk
factor
ipd
suggest
adopt
holist
approach
combin
quantif
np
pneumococc
load
serotyp
identif
quantif
blood
marker
could
substanti
increas
overal
diagnost
yield
comprehens
approach
would
especi
suitabl
refer
healthcar
set
laboratori
infrastructur
equip
routin
perform
techniqu
studi
variou
import
limit
first
total
sampl
size
small
although
analysi
seem
suffici
power
show
real
differ
np
pneumococc
load
case
control
differ
observ
group
biolog
plausibl
prove
concept
second
spite
fact
casecontrol
approach
appear
suitabl
test
project
hypothesi
restrict
select
control
short
period
time
case
recruit
could
introduc
import
bias
result
particularli
relat
variabl
patient
characterist
yeartoyear
variat
differ
infect
bacteri
viral
assess
incid
infect
pneumococc
serotyp
compar
analysi
perform
control
potenti
confound
effect
season
np
colon
densiti
howev
small
sampl
size
hinder
capac
evalu
yeartoyear
variat
circul
serotyp
third
hiv
statu
control
unknown
reason
suspect
could
consider
differ
report
healthi
children
commun
low
hiv
preval
rang
document
moreov
perform
subanalysi
case
signific
differ
mean
np
pneumococc
load
hiv
coinfect
coinfect
subject
suggest
factor
substanti
increas
np
densiti
pneumococcu
young
patient
final
result
drawn
popul
high
background
preval
rate
nasopharyng
pneumococc
carriag
previous
describ
remain
seen
whether
threshold
obtain
studi
would
remain
valid
area
lower
carriag
rate
conclus
propos
new
diagnost
method
coupl
use
easili
obtain
noninvas
np
aspir
rapid
accur
quantif
np
pneumococc
load
lyta
realtim
pcr
surrog
marker
ipd
children
valid
requir
confirm
clinic
util
method
support
inform
dataset
support
data
manuscript
result
xl
